context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
The Company has recorded a valuation allowance of $ 855 million on its foreign tax credit (“FTC”) carryover of $ 1.0 billion as of December 31, 2024, resulting in an FTC net deferred tax asset of approximately $ 153 million. The FTCs are attributable to the Macau Special Gaming Tax, which is 35% of gross gaming revenue... | text | 153 | monetaryItemType | text: <entity> 153 </entity> <entity type> monetaryItemType </entity type> <context> The Company has recorded a valuation allowance of $ 855 million on its foreign tax credit (“FTC”) carryover of $ 1.0 billion as of December 31, 2024, resulting in an FTC net deferred tax asset of approximately $ 153 million. The FTCs a... | us-gaap:DeferredTaxAssetsLiabilitiesNet |
At December 31, 2024, gross foreign net operating loss carryforwards consisted primarily of a complementary tax exempt net operating loss (“NOL”) carryforward of $ 1.3 billion at MGM Grand Paradise resulting from non-gaming operations that will expire if not utilized in years 2025 through 2027. | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, gross foreign net operating loss carryforwards consisted primarily of a complementary tax exempt net operating loss (“NOL”) carryforward of $ 1.3 billion at MGM Grand Paradise resulting from non-gaming operations ... | us-gaap:OperatingLossCarryforwards |
As of December 31, 2024, there is a $ 174 million valuation allowance on certain foreign deferred tax assets, which relates primarily to MGM Grand Paradise’s NOLs. | text | 174 | monetaryItemType | text: <entity> 174 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there is a $ 174 million valuation allowance on certain foreign deferred tax assets, which relates primarily to MGM Grand Paradise’s NOLs. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
The Company has NOLs in some of the states in which it operates that total $ 234 million as of December 31, 2024, which equates to deferred tax assets of $ 14 million after federal tax effect and before valuation allowance. The NOL carryforwards in most of the states will expire, if not utilized, between 2025 through 2... | text | 234 | monetaryItemType | text: <entity> 234 </entity> <entity type> monetaryItemType </entity type> <context> The Company has NOLs in some of the states in which it operates that total $ 234 million as of December 31, 2024, which equates to deferred tax assets of $ 14 million after federal tax effect and before valuation allowance. The NOL car... | us-gaap:OperatingLossCarryforwards |
The Company has NOLs in some of the states in which it operates that total $ 234 million as of December 31, 2024, which equates to deferred tax assets of $ 14 million after federal tax effect and before valuation allowance. The NOL carryforwards in most of the states will expire, if not utilized, between 2025 through 2... | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> The Company has NOLs in some of the states in which it operates that total $ 234 million as of December 31, 2024, which equates to deferred tax assets of $ 14 million after federal tax effect and before valuation allowance. The NOL carr... | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal |
The Company has NOLs in some of the states in which it operates that total $ 234 million as of December 31, 2024, which equates to deferred tax assets of $ 14 million after federal tax effect and before valuation allowance. The NOL carryforwards in most of the states will expire, if not utilized, between 2025 through 2... | text | 12 | monetaryItemType | text: <entity> 12 </entity> <entity type> monetaryItemType </entity type> <context> The Company has NOLs in some of the states in which it operates that total $ 234 million as of December 31, 2024, which equates to deferred tax assets of $ 14 million after federal tax effect and before valuation allowance. The NOL carr... | us-gaap:DeferredTaxAssetsValuationAllowance |
. The Company leases the real estate assets of Bellagio from a venture in which it has a 5 % ownership interest (the “Bellagio REIT Venture”). The Bellagio lease commenced November 15, 2019 and has an initial term of 30 years with two 10 -year renewal periods, exercisable at the Company’s option, with a fixed 2 % rent ... | text | 5 | percentItemType | text: <entity> 5 </entity> <entity type> percentItemType </entity type> <context> . The Company leases the real estate assets of Bellagio from a venture in which it has a 5 % ownership interest (the “Bellagio REIT Venture”). The Bellagio lease commenced November 15, 2019 and has an initial term of 30 years with two 10 ... | us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners |
As of December 31, 2024 and 2023, operating lease ROU assets, net included $ 3.4 billion and $ 3.5 billion related to the Bellagio lease, respectively. | text | 3.4 | monetaryItemType | text: <entity> 3.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, operating lease ROU assets, net included $ 3.4 billion and $ 3.5 billion related to the Bellagio lease, respectively. </context> | us-gaap:OperatingLeaseRightOfUseAsset |
As of December 31, 2024 and 2023, operating lease ROU assets, net included $ 3.4 billion and $ 3.5 billion related to the Bellagio lease, respectively. | text | 3.5 | monetaryItemType | text: <entity> 3.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, operating lease ROU assets, net included $ 3.4 billion and $ 3.5 billion related to the Bellagio lease, respectively. </context> | us-gaap:OperatingLeaseRightOfUseAsset |
As of December 31, 2024 and 2023, operating lease liabilities – long-term included $ 3.8 billion related to the Bellagio lease. As of December 31, 2024, operating lease liabilities – current included $ 3 million related to the Bellagio lease. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, operating lease liabilities – long-term included $ 3.8 billion related to the Bellagio lease. As of December 31, 2024, operating lease liabilities – current included $ 3 million related to the Bellagio l... | us-gaap:OperatingLeaseLiabilityCurrent |
In connection with this cybersecurity issue, the Company became subject to consumer class actions in U.S. federal and state courts. These class actions assert a variety of common law and statutory claims based on allegations that the Company failed to use reasonable security procedures and practices to safeguard custom... | text | 45 | monetaryItemType | text: <entity> 45 </entity> <entity type> monetaryItemType </entity type> <context> In connection with this cybersecurity issue, the Company became subject to consumer class actions in U.S. federal and state courts. These class actions assert a variety of common law and statutory claims based on allegations that the Co... | us-gaap:PaymentsForLegalSettlements |
In connection with the issuance of the gaming concession in January 2023, bank guarantees were provided to the government of Macau in the amount of MOP 1 billion (approximately $ 125 million as of December 31, 2024) to warrant the fulfillment of labor liabilities and of damages or losses that may result if there is non... | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the issuance of the gaming concession in January 2023, bank guarantees were provided to the government of Macau in the amount of MOP 1 billion (approximately $ 125 million as of December 31, 2024) to warrant the fulfil... | us-gaap:GuaranteeObligationsMaximumExposure |
In connection with the issuance of the gaming concession in January 2023, bank guarantees were provided to the government of Macau in the amount of MOP 1 billion (approximately $ 125 million as of December 31, 2024) to warrant the fulfillment of labor liabilities and of damages or losses that may result if there is non... | text | 125 | monetaryItemType | text: <entity> 125 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the issuance of the gaming concession in January 2023, bank guarantees were provided to the government of Macau in the amount of MOP 1 billion (approximately $ 125 million as of December 31, 2024) to warrant the fulf... | us-gaap:GuaranteeObligationsMaximumExposure |
In connection with the issuance of the gaming concession in January 2023, bank guarantees were provided to the government of Macau in the amount of MOP 1 billion (approximately $ 125 million as of December 31, 2024) to warrant the fulfillment of labor liabilities and of damages or losses that may result if there is non... | text | 700 | monetaryItemType | text: <entity> 700 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the issuance of the gaming concession in January 2023, bank guarantees were provided to the government of Macau in the amount of MOP 1 billion (approximately $ 125 million as of December 31, 2024) to warrant the fulf... | us-gaap:GuaranteeObligationsMaximumExposure |
In connection with the issuance of the gaming concession in January 2023, bank guarantees were provided to the government of Macau in the amount of MOP 1 billion (approximately $ 125 million as of December 31, 2024) to warrant the fulfillment of labor liabilities and of damages or losses that may result if there is non... | text | 87 | monetaryItemType | text: <entity> 87 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the issuance of the gaming concession in January 2023, bank guarantees were provided to the government of Macau in the amount of MOP 1 billion (approximately $ 125 million as of December 31, 2024) to warrant the fulfi... | us-gaap:GuaranteeObligationsMaximumExposure |
The Company provides a shortfall guarantee of the $ 3.01 billion principal amount of indebtedness (and any interest accrued and unpaid thereon) of the landlord of Bellagio, Bellagio REIT Venture, which is a VIE and a related party, for which such indebtedness matures in 2029. The terms of the shortfall guarantee provid... | text | 3.01 | monetaryItemType | text: <entity> 3.01 </entity> <entity type> monetaryItemType </entity type> <context> The Company provides a shortfall guarantee of the $ 3.01 billion principal amount of indebtedness (and any interest accrued and unpaid thereon) of the landlord of Bellagio, Bellagio REIT Venture, which is a VIE and a related party, fo... | us-gaap:GuaranteeObligationsMaximumExposure |
The Company provides for guarantees (1) in the amount of 12.65 billion yen (approximately $ 80 million as of December 31, 2024) for | text | 12.65 | monetaryItemType | text: <entity> 12.65 </entity> <entity type> monetaryItemType </entity type> <context> The Company provides for guarantees (1) in the amount of 12.65 billion yen (approximately $ 80 million as of December 31, 2024) for </context> | us-gaap:GuaranteeObligationsMaximumExposure |
The Company provides for guarantees (1) in the amount of 12.65 billion yen (approximately $ 80 million as of December 31, 2024) for | text | 80 | monetaryItemType | text: <entity> 80 </entity> <entity type> monetaryItemType </entity type> <context> The Company provides for guarantees (1) in the amount of 12.65 billion yen (approximately $ 80 million as of December 31, 2024) for </context> | us-gaap:GuaranteeObligationsMaximumExposure |
of Osaka IR KK’s obligations to Osaka under various agreements related to the venture’s development of an integrated resort in Osaka, Japan and (2) of an uncapped amount to provide funding to Osaka IR KK, if necessary, for the completion of the construction and full opening of the integrated resort. The guarantees expi... | text | 274 | monetaryItemType | text: <entity> 274 </entity> <entity type> monetaryItemType </entity type> <context> of Osaka IR KK’s obligations to Osaka under various agreements related to the venture’s development of an integrated resort in Osaka, Japan and (2) of an uncapped amount to provide funding to Osaka IR KK, if necessary, for the completi... | us-gaap:EquityMethodInvestments |
The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as of December 31, 2024) remains to be funded as of December 31, 2024. The amount and tim... | text | 271 | monetaryItemType | text: <entity> 271 </entity> <entity type> monetaryItemType </entity type> <context> The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as o... | us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted |
The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as of December 31, 2024) remains to be funded as of December 31, 2024. The amount and tim... | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as o... | us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted |
The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as of December 31, 2024) remains to be funded as of December 31, 2024. The amount and tim... | text | 25.2 | monetaryItemType | text: <entity> 25.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as ... | us-gaap:PaymentsToAcquireEquityMethodInvestments |
The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as of December 31, 2024) remains to be funded as of December 31, 2024. The amount and tim... | text | 157 | monetaryItemType | text: <entity> 157 </entity> <entity type> monetaryItemType </entity type> <context> The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as o... | us-gaap:PaymentsToAcquireEquityMethodInvestments |
The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as of December 31, 2024) remains to be funded as of December 31, 2024. The amount and tim... | text | 10.3 | monetaryItemType | text: <entity> 10.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as ... | us-gaap:PaymentsToAcquireEquityMethodInvestments |
The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as of December 31, 2024) remains to be funded as of December 31, 2024. The amount and tim... | text | 69 | monetaryItemType | text: <entity> 69 </entity> <entity type> monetaryItemType </entity type> <context> The Company has commitments to fund Osaka IR KK for its proportionate share of the unfinanced portion of Osaka IR KK’s development project, of which an estimated amount of approximately 271 billion yen (approximately $ 1.7 billion as of... | us-gaap:PaymentsToAcquireEquityMethodInvestments |
During the year ended December 31, 2022, the Company repurchased approximately 76 million shares of its common stock for an aggregate amount of $ 2.8 billion, which included the February 2022 repurchase of 4.5 million shares for an aggregate amount of $ 202.5 million from funds managed by Corvex Management LP, a relate... | text | 76 | sharesItemType | text: <entity> 76 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2022, the Company repurchased approximately 76 million shares of its common stock for an aggregate amount of $ 2.8 billion, which included the February 2022 repurchase of 4.5 million shares for an aggreg... | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
During the year ended December 31, 2022, the Company repurchased approximately 76 million shares of its common stock for an aggregate amount of $ 2.8 billion, which included the February 2022 repurchase of 4.5 million shares for an aggregate amount of $ 202.5 million from funds managed by Corvex Management LP, a relate... | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, the Company repurchased approximately 76 million shares of its common stock for an aggregate amount of $ 2.8 billion, which included the February 2022 repurchase of 4.5 million shares for an agg... | us-gaap:StockRepurchasedAndRetiredDuringPeriodValue |
During the year ended December 31, 2022, the Company repurchased approximately 76 million shares of its common stock for an aggregate amount of $ 2.8 billion, which included the February 2022 repurchase of 4.5 million shares for an aggregate amount of $ 202.5 million from funds managed by Corvex Management LP, a relate... | text | 4.5 | sharesItemType | text: <entity> 4.5 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2022, the Company repurchased approximately 76 million shares of its common stock for an aggregate amount of $ 2.8 billion, which included the February 2022 repurchase of 4.5 million shares for an aggre... | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
During the year ended December 31, 2022, the Company repurchased approximately 76 million shares of its common stock for an aggregate amount of $ 2.8 billion, which included the February 2022 repurchase of 4.5 million shares for an aggregate amount of $ 202.5 million from funds managed by Corvex Management LP, a relate... | text | 202.5 | monetaryItemType | text: <entity> 202.5 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, the Company repurchased approximately 76 million shares of its common stock for an aggregate amount of $ 2.8 billion, which included the February 2022 repurchase of 4.5 million shares for an a... | us-gaap:StockRepurchasedAndRetiredDuringPeriodValue |
During the year ended December 31, 2023, the Company repurchased approximately 54 million shares of its common stock for an aggregate amount of $ 2.3 billion. Repurchased shares were retired. In connection with these repurchases, the March 2022 $ 2.0 billion stock repurchase plan was completed. | text | 54 | sharesItemType | text: <entity> 54 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2023, the Company repurchased approximately 54 million shares of its common stock for an aggregate amount of $ 2.3 billion. Repurchased shares were retired. In connection with these repurchases, the Marc... | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
During the year ended December 31, 2023, the Company repurchased approximately 54 million shares of its common stock for an aggregate amount of $ 2.3 billion. Repurchased shares were retired. In connection with these repurchases, the March 2022 $ 2.0 billion stock repurchase plan was completed. | text | 2.3 | monetaryItemType | text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company repurchased approximately 54 million shares of its common stock for an aggregate amount of $ 2.3 billion. Repurchased shares were retired. In connection with these repurchases, the M... | us-gaap:StockRepurchasedAndRetiredDuringPeriodValue |
During the year ended December 31, 2024, the Company repurchased approximately 33 million shares of its common stock for an aggregate amount of $ 1.4 billion. Repurchased shares were retired. In connection with these repurchases, the February 2023 $ 2.0 billion stock repurchase plan was completed. As of December 31, 20... | text | 33 | sharesItemType | text: <entity> 33 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, the Company repurchased approximately 33 million shares of its common stock for an aggregate amount of $ 1.4 billion. Repurchased shares were retired. In connection with these repurchases, the Febr... | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
During the year ended December 31, 2024, the Company repurchased approximately 33 million shares of its common stock for an aggregate amount of $ 1.4 billion. Repurchased shares were retired. In connection with these repurchases, the February 2023 $ 2.0 billion stock repurchase plan was completed. As of December 31, 20... | text | 1.4 | monetaryItemType | text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company repurchased approximately 33 million shares of its common stock for an aggregate amount of $ 1.4 billion. Repurchased shares were retired. In connection with these repurchases, the F... | us-gaap:StockRepurchasedAndRetiredDuringPeriodValue |
During the year ended December 31, 2024, the Company repurchased approximately 33 million shares of its common stock for an aggregate amount of $ 1.4 billion. Repurchased shares were retired. In connection with these repurchases, the February 2023 $ 2.0 billion stock repurchase plan was completed. As of December 31, 20... | text | 826 | monetaryItemType | text: <entity> 826 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company repurchased approximately 33 million shares of its common stock for an aggregate amount of $ 1.4 billion. Repurchased shares were retired. In connection with these repurchases, the F... | us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 |
Subsequent to December 31, 2024, the Company repurchased approximately 9 million shares of its common stock for an aggregate amount of $ 307 million, excluding excise tax. Repurchased shares were retired. | text | 9 | sharesItemType | text: <entity> 9 </entity> <entity type> sharesItemType </entity type> <context> Subsequent to December 31, 2024, the Company repurchased approximately 9 million shares of its common stock for an aggregate amount of $ 307 million, excluding excise tax. Repurchased shares were retired. </context> | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
Subsequent to December 31, 2024, the Company repurchased approximately 9 million shares of its common stock for an aggregate amount of $ 307 million, excluding excise tax. Repurchased shares were retired. | text | 307 | monetaryItemType | text: <entity> 307 </entity> <entity type> monetaryItemType </entity type> <context> Subsequent to December 31, 2024, the Company repurchased approximately 9 million shares of its common stock for an aggregate amount of $ 307 million, excluding excise tax. Repurchased shares were retired. </context> | us-gaap:StockRepurchasedAndRetiredDuringPeriodValue |
On May 4, 2022, the MGM Resorts 2022 Omnibus Incentive Plan (“2022 Omnibus Plan”) was approved and replaced and superseded the amended and restated MGM Resorts 2005 Omnibus Incentive Plan. The Company’s 2022 Omnibus Plan allows it to grant up to approximately 18 million shares or stock-based awards, such as stock optio... | text | 18 | sharesItemType | text: <entity> 18 </entity> <entity type> sharesItemType </entity type> <context> On May 4, 2022, the MGM Resorts 2022 Omnibus Incentive Plan (“2022 Omnibus Plan”) was approved and replaced and superseded the amended and restated MGM Resorts 2005 Omnibus Incentive Plan. The Company’s 2022 Omnibus Plan allows it to gran... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
As of December 31, 2024, the Company had an aggregate of approximately 14 million shares of common stock available for grant as stock-based awards under the 2022 Omnibus Plan. Additionally, as of December 31, 2024, the Company had approximately 6 million aggregate RSUs and PSUs outstanding, including deferred share uni... | text | 14 | sharesItemType | text: <entity> 14 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, the Company had an aggregate of approximately 14 million shares of common stock available for grant as stock-based awards under the 2022 Omnibus Plan. Additionally, as of December 31, 2024, the Company had approxi... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
As of December 31, 2024, the Company had an aggregate of approximately 14 million shares of common stock available for grant as stock-based awards under the 2022 Omnibus Plan. Additionally, as of December 31, 2024, the Company had approximately 6 million aggregate RSUs and PSUs outstanding, including deferred share uni... | text | 6 | sharesItemType | text: <entity> 6 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, the Company had an aggregate of approximately 14 million shares of common stock available for grant as stock-based awards under the 2022 Omnibus Plan. Additionally, as of December 31, 2024, the Company had approxim... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber |
. Pursuant to its collective bargaining agreements referenced above, the Company also contributes to UNITE HERE Health (the “Health Fund”), which provides healthcare benefits to its active and retired members. The Company contributed $ 237 million, $ 230 million, and $ 218 million to the Health Fund for the years ended... | text | 237 | monetaryItemType | text: <entity> 237 </entity> <entity type> monetaryItemType </entity type> <context> . Pursuant to its collective bargaining agreements referenced above, the Company also contributes to UNITE HERE Health (the “Health Fund”), which provides healthcare benefits to its active and retired members. The Company contributed $... | us-gaap:MultiemployerPlanPensionSignificantEmployerContributionCost |
. Pursuant to its collective bargaining agreements referenced above, the Company also contributes to UNITE HERE Health (the “Health Fund”), which provides healthcare benefits to its active and retired members. The Company contributed $ 237 million, $ 230 million, and $ 218 million to the Health Fund for the years ended... | text | 230 | monetaryItemType | text: <entity> 230 </entity> <entity type> monetaryItemType </entity type> <context> . Pursuant to its collective bargaining agreements referenced above, the Company also contributes to UNITE HERE Health (the “Health Fund”), which provides healthcare benefits to its active and retired members. The Company contributed $... | us-gaap:MultiemployerPlanPensionSignificantEmployerContributionCost |
. Pursuant to its collective bargaining agreements referenced above, the Company also contributes to UNITE HERE Health (the “Health Fund”), which provides healthcare benefits to its active and retired members. The Company contributed $ 237 million, $ 230 million, and $ 218 million to the Health Fund for the years ended... | text | 218 | monetaryItemType | text: <entity> 218 </entity> <entity type> monetaryItemType </entity type> <context> . Pursuant to its collective bargaining agreements referenced above, the Company also contributes to UNITE HERE Health (the “Health Fund”), which provides healthcare benefits to its active and retired members. The Company contributed $... | us-gaap:MultiemployerPlanPensionSignificantEmployerContributionCost |
On March 31, 2021, we completed the sale of our oncology business to Servier Pharmaceuticals, LLC, or Servier, which represented a discontinued operation. The transaction included the sale of our oncology business, including TIBSOVO®, our clinical-stage product candidates vorasidenib, AG-270 and AG-636, and our oncolog... | text | 1.8 | monetaryItemType | text: <entity> 1.8 </entity> <entity type> monetaryItemType </entity type> <context> On March 31, 2021, we completed the sale of our oncology business to Servier Pharmaceuticals, LLC, or Servier, which represented a discontinued operation. The transaction included the sale of our oncology business, including TIBSOVO®, ... | us-gaap:ProceedsFromDivestitureOfBusinesses |
On March 31, 2021, we completed the sale of our oncology business to Servier Pharmaceuticals, LLC, or Servier, which represented a discontinued operation. The transaction included the sale of our oncology business, including TIBSOVO®, our clinical-stage product candidates vorasidenib, AG-270 and AG-636, and our oncolog... | text | 200.0 | monetaryItemType | text: <entity> 200.0 </entity> <entity type> monetaryItemType </entity type> <context> On March 31, 2021, we completed the sale of our oncology business to Servier Pharmaceuticals, LLC, or Servier, which represented a discontinued operation. The transaction included the sale of our oncology business, including TIBSOVO®... | us-gaap:GainContingencyUnrecordedAmount |
As of December 31, 2023, we had cash, cash equivalents and marketable securities of $ 806.4 million. Although we have incurred recurring losses and expect to continue to incur losses for the foreseeable future, we expect our cash, cash equivalents and marketable securities to be sufficient to fund current operations fo... | text | 806.4 | monetaryItemType | text: <entity> 806.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, we had cash, cash equivalents and marketable securities of $ 806.4 million. Although we have incurred recurring losses and expect to continue to incur losses for the foreseeable future, we expect our cash, ca... | us-gaap:CashCashEquivalentsAndShortTermInvestments |
Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker or decision-making group in making decisions on how to allocate resources and assess performance. Our chief operating decision maker is t... | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker or decision-making group in making decisions on how t... | us-gaap:NumberOfOperatingSegments |
There were no transfers between Level 1 and Level 2 and we had no financial assets or liabilities that were classified as Level 3 at any point during the year ended December 31, 2023. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> There were no transfers between Level 1 and Level 2 and we had no financial assets or liabilities that were classified as Level 3 at any point during the year ended December 31, 2023. </context> | us-gaap:FairValueNetAssetLiability |
At December 31, 2023 and 2022, we held 151 and 259 debt securities, respectively, that were in an unrealized loss position for less than one year. We did no t record an allowance for credit losses as of December 31, 2023 and 2022 related to these securities. The aggregate fair value of debt securities in an unrealized ... | text | 151 | integerItemType | text: <entity> 151 </entity> <entity type> integerItemType </entity type> <context> At December 31, 2023 and 2022, we held 151 and 259 debt securities, respectively, that were in an unrealized loss position for less than one year. We did no t record an allowance for credit losses as of December 31, 2023 and 2022 relate... | us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions |
At December 31, 2023 and 2022, we held 151 and 259 debt securities, respectively, that were in an unrealized loss position for less than one year. We did no t record an allowance for credit losses as of December 31, 2023 and 2022 related to these securities. The aggregate fair value of debt securities in an unrealized ... | text | 259 | integerItemType | text: <entity> 259 </entity> <entity type> integerItemType </entity type> <context> At December 31, 2023 and 2022, we held 151 and 259 debt securities, respectively, that were in an unrealized loss position for less than one year. We did no t record an allowance for credit losses as of December 31, 2023 and 2022 relate... | us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions |
At December 31, 2023 and 2022, we held 151 and 259 debt securities, respectively, that were in an unrealized loss position for less than one year. We did no t record an allowance for credit losses as of December 31, 2023 and 2022 related to these securities. The aggregate fair value of debt securities in an unrealized ... | text | 513.5 | monetaryItemType | text: <entity> 513.5 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023 and 2022, we held 151 and 259 debt securities, respectively, that were in an unrealized loss position for less than one year. We did no t record an allowance for credit losses as of December 31, 2023 and 2022 rel... | us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition |
At December 31, 2023 and 2022, we held 151 and 259 debt securities, respectively, that were in an unrealized loss position for less than one year. We did no t record an allowance for credit losses as of December 31, 2023 and 2022 related to these securities. The aggregate fair value of debt securities in an unrealized ... | text | 868.2 | monetaryItemType | text: <entity> 868.2 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023 and 2022, we held 151 and 259 debt securities, respectively, that were in an unrealized loss position for less than one year. We did no t record an allowance for credit losses as of December 31, 2023 and 2022 rel... | us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition |
In arriving at the operating lease liabilities as of December 31, 2023, we applied the weighted-average incremental borrowing rate of 5.7 % from inception over a weighted-average remaining lease term of 4.2 years. In arriving at the operating lease liabilities as of December 31, 2022, we applied the weighted-average in... | text | 5.7 | percentItemType | text: <entity> 5.7 </entity> <entity type> percentItemType </entity type> <context> In arriving at the operating lease liabilities as of December 31, 2023, we applied the weighted-average incremental borrowing rate of 5.7 % from inception over a weighted-average remaining lease term of 4.2 years. In arriving at the ope... | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent |
We provided our landlord a security deposit of $ 2.9 million as security for our leases, which is included within other non-current assets on our consolidated balance sheet. | text | 2.9 | monetaryItemType | text: <entity> 2.9 </entity> <entity type> monetaryItemType </entity type> <context> We provided our landlord a security deposit of $ 2.9 million as security for our leases, which is included within other non-current assets on our consolidated balance sheet. </context> | us-gaap:LettersOfCreditOutstandingAmount |
We recorded operating sublease income of $ 6.1 million and $ 4.1 million for the years ended December 31, 2023 and December 31, 2022, respectively, in other income, net in the consolidated statements of operations. We received a security deposit from our sublessee of approximately $ 1.2 million which is recorded within... | text | 6.1 | monetaryItemType | text: <entity> 6.1 </entity> <entity type> monetaryItemType </entity type> <context> We recorded operating sublease income of $ 6.1 million and $ 4.1 million for the years ended December 31, 2023 and December 31, 2022, respectively, in other income, net in the consolidated statements of operations. We received a securi... | us-gaap:SubleaseIncome |
We recorded operating sublease income of $ 6.1 million and $ 4.1 million for the years ended December 31, 2023 and December 31, 2022, respectively, in other income, net in the consolidated statements of operations. We received a security deposit from our sublessee of approximately $ 1.2 million which is recorded within... | text | 4.1 | monetaryItemType | text: <entity> 4.1 </entity> <entity type> monetaryItemType </entity type> <context> We recorded operating sublease income of $ 6.1 million and $ 4.1 million for the years ended December 31, 2023 and December 31, 2022, respectively, in other income, net in the consolidated statements of operations. We received a securi... | us-gaap:SubleaseIncome |
We recorded operating sublease income of $ 6.1 million and $ 4.1 million for the years ended December 31, 2023 and December 31, 2022, respectively, in other income, net in the consolidated statements of operations. We received a security deposit from our sublessee of approximately $ 1.2 million which is recorded within... | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> We recorded operating sublease income of $ 6.1 million and $ 4.1 million for the years ended December 31, 2023 and December 31, 2022, respectively, in other income, net in the consolidated statements of operations. We received a securi... | us-gaap:SecurityDepositLiability |
As of December 31, 2023, the maximum number of shares reserved under the 2013 Plan, the 2023 Plan and the inducement grants described above was 12,004,551 , and we had 4,989,341 shares available for future issuance under the 2023 Plan. | text | 12004551 | sharesItemType | text: <entity> 12004551 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2023, the maximum number of shares reserved under the 2013 Plan, the 2023 Plan and the inducement grants described above was 12,004,551 , and we had 4,989,341 shares available for future issuance under the 2023 Pl... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
As of December 31, 2023, the maximum number of shares reserved under the 2013 Plan, the 2023 Plan and the inducement grants described above was 12,004,551 , and we had 4,989,341 shares available for future issuance under the 2023 Plan. | text | 4989341 | sharesItemType | text: <entity> 4989341 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2023, the maximum number of shares reserved under the 2013 Plan, the 2023 Plan and the inducement grants described above was 12,004,551 , and we had 4,989,341 shares available for future issuance under the 2023 Pla... | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, $ 0.3 million and $ 8.5 million during the years ended December 31, 2023, 2022 and 2021... | text | 14.32 | perShareItemType | text: <entity> 14.32 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, $ 0.3 million and $ 8.5 million during the years ended December 31, 2023, 2022 and 2021... | text | 15.64 | perShareItemType | text: <entity> 15.64 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, $ 0.3 million and $ 8.5 million during the years ended December 31, 2023, 2022 and 2021... | text | 31.20 | perShareItemType | text: <entity> 31.20 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, $ 0.3 million and $ 8.5 million during the years ended December 31, 2023, 2022 and 2021... | text | 2.9 | monetaryItemType | text: <entity> 2.9 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, $ ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, $ 0.3 million and $ 8.5 million during the years ended December 31, 2023, 2022 and 2021... | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, $ ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, $ 0.3 million and $ 8.5 million during the years ended December 31, 2023, 2022 and 2021... | text | 8.5 | monetaryItemType | text: <entity> 8.5 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant date fair value of options granted was $ 14.32 , $ 15.64 and $ 31.20 during the years ended December 31, 2023, 2022 and 2021, respectively. The total intrinsic value of options exercised was $ 2.9 million, $ ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
At December 31, 2023, the total unrecognized compensation expense related to unvested stock option awards was $ 27.8 million, which we expect to recognize over a weighted-average period of approximately 2.40 years. | text | 27.8 | monetaryItemType | text: <entity> 27.8 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, the total unrecognized compensation expense related to unvested stock option awards was $ 27.8 million, which we expect to recognize over a weighted-average period of approximately 2.40 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions |
As of December 31, 2023, there was approximately $ 22.6 million of total unrecognized compensation expense related to RSUs, which we expect to be recognized over a weighted-average period of 1.75 years. | text | 22.6 | monetaryItemType | text: <entity> 22.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, there was approximately $ 22.6 million of total unrecognized compensation expense related to RSUs, which we expect to be recognized over a weighted-average period of 1.75 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions |
Included in unvested shares were 145,023 shares with performance-based vesting criteria that were considered probable of achievement at December 31, 2023 and vested in January 2024. Stock-based compensation expense associated with these PSUs is recognized if the underlying performance condition is considered probable o... | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> Included in unvested shares were 145,023 shares with performance-based vesting criteria that were considered probable of achievement at December 31, 2023 and vested in January 2024. Stock-based compensation expense associated with these... | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions |
As of December 31, 2023, there was no remaining unrecognized compensation expense related to MSUs. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, there was no remaining unrecognized compensation expense related to MSUs. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions |
In June 2013, our Board of Directors adopted, and in July 2013 our stockholders approved, the 2013 Employee Stock Purchase Plan, or the 2013 ESPP. On January 1, 2023, the annual increase for the 2013 ESPP resulted in an additional 509,091 shares authorized for issuance. We issued 112,832 shares and 104,867 shares durin... | text | 509091 | sharesItemType | text: <entity> 509091 </entity> <entity type> sharesItemType </entity type> <context> In June 2013, our Board of Directors adopted, and in July 2013 our stockholders approved, the 2013 Employee Stock Purchase Plan, or the 2013 ESPP. On January 1, 2023, the annual increase for the 2013 ESPP resulted in an additional 509... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized |
In June 2013, our Board of Directors adopted, and in July 2013 our stockholders approved, the 2013 Employee Stock Purchase Plan, or the 2013 ESPP. On January 1, 2023, the annual increase for the 2013 ESPP resulted in an additional 509,091 shares authorized for issuance. We issued 112,832 shares and 104,867 shares durin... | text | 112832 | sharesItemType | text: <entity> 112832 </entity> <entity type> sharesItemType </entity type> <context> In June 2013, our Board of Directors adopted, and in July 2013 our stockholders approved, the 2013 Employee Stock Purchase Plan, or the 2013 ESPP. On January 1, 2023, the annual increase for the 2013 ESPP resulted in an additional 509... | us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans |
In June 2013, our Board of Directors adopted, and in July 2013 our stockholders approved, the 2013 Employee Stock Purchase Plan, or the 2013 ESPP. On January 1, 2023, the annual increase for the 2013 ESPP resulted in an additional 509,091 shares authorized for issuance. We issued 112,832 shares and 104,867 shares durin... | text | 104867 | sharesItemType | text: <entity> 104867 </entity> <entity type> sharesItemType </entity type> <context> In June 2013, our Board of Directors adopted, and in July 2013 our stockholders approved, the 2013 Employee Stock Purchase Plan, or the 2013 ESPP. On January 1, 2023, the annual increase for the 2013 ESPP resulted in an additional 509... | us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans |
In June 2013, our Board of Directors adopted, and in July 2013 our stockholders approved, the 2013 Employee Stock Purchase Plan, or the 2013 ESPP. On January 1, 2023, the annual increase for the 2013 ESPP resulted in an additional 509,091 shares authorized for issuance. We issued 112,832 shares and 104,867 shares durin... | text | 2363636 | sharesItemType | text: <entity> 2363636 </entity> <entity type> sharesItemType </entity type> <context> In June 2013, our Board of Directors adopted, and in July 2013 our stockholders approved, the 2013 Employee Stock Purchase Plan, or the 2013 ESPP. On January 1, 2023, the annual increase for the 2013 ESPP resulted in an additional 50... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee |
In June 2013, our Board of Directors adopted, and in July 2013 our stockholders approved, the 2013 Employee Stock Purchase Plan, or the 2013 ESPP. On January 1, 2023, the annual increase for the 2013 ESPP resulted in an additional 509,091 shares authorized for issuance. We issued 112,832 shares and 104,867 shares durin... | text | 1686039 | sharesItemType | text: <entity> 1686039 </entity> <entity type> sharesItemType </entity type> <context> In June 2013, our Board of Directors adopted, and in July 2013 our stockholders approved, the 2013 Employee Stock Purchase Plan, or the 2013 ESPP. On January 1, 2023, the annual increase for the 2013 ESPP resulted in an additional 50... | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
We have never paid, and do not anticipate paying, any cash dividends in the foreseeable future, and, therefore, use an expected dividend yield of zero in the option-pricing model. | text | zero | percentItemType | text: <entity> zero </entity> <entity type> percentItemType </entity type> <context> We have never paid, and do not anticipate paying, any cash dividends in the foreseeable future, and, therefore, use an expected dividend yield of zero in the option-pricing model. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate |
The Tax Cuts and Jobs Act (TCJA) requires taxpayers to capitalize and amortize research and experimental expenditures under Internal Revenue Code section 174 for tax years beginning after December 31, 2021. The Company capitalized research and experimental costs of $ 232.7 million and $ 261.4 million for the years ende... | text | 232.7 | monetaryItemType | text: <entity> 232.7 </entity> <entity type> monetaryItemType </entity type> <context> The Tax Cuts and Jobs Act (TCJA) requires taxpayers to capitalize and amortize research and experimental expenditures under Internal Revenue Code section 174 for tax years beginning after December 31, 2021. The Company capitalized re... | us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts |
The Tax Cuts and Jobs Act (TCJA) requires taxpayers to capitalize and amortize research and experimental expenditures under Internal Revenue Code section 174 for tax years beginning after December 31, 2021. The Company capitalized research and experimental costs of $ 232.7 million and $ 261.4 million for the years ende... | text | 261.4 | monetaryItemType | text: <entity> 261.4 </entity> <entity type> monetaryItemType </entity type> <context> The Tax Cuts and Jobs Act (TCJA) requires taxpayers to capitalize and amortize research and experimental expenditures under Internal Revenue Code section 174 for tax years beginning after December 31, 2021. The Company capitalized re... | us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts |
As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31, 2023, we also had available research and development tax credits for federal and stat... | text | 131.7 | monetaryItemType | text: <entity> 131.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31... | us-gaap:OperatingLossCarryforwards |
As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31, 2023, we also had available research and development tax credits for federal and stat... | text | 502.4 | monetaryItemType | text: <entity> 502.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31... | us-gaap:OperatingLossCarryforwards |
As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31, 2023, we also had available research and development tax credits for federal and stat... | text | 65.2 | monetaryItemType | text: <entity> 65.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31,... | us-gaap:OperatingLossCarryforwards |
As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31, 2023, we also had available research and development tax credits for federal and stat... | text | 25.5 | monetaryItemType | text: <entity> 25.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31,... | us-gaap:TaxCreditCarryforwardAmount |
As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31, 2023, we also had available research and development tax credits for federal and stat... | text | 28.1 | monetaryItemType | text: <entity> 28.1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31,... | us-gaap:TaxCreditCarryforwardAmount |
As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31, 2023, we also had available research and development tax credits for federal and stat... | text | 132.9 | monetaryItemType | text: <entity> 132.9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, we had net operating loss carryforwards, or NOLs, available to reduce federal, state and foreign income taxes of approximately $ 131.7 million, $ 502.4 million and $ 65.2 million, respectively. At December 31... | us-gaap:TaxCreditCarryforwardAmount |
As required by ASC 740, we have evaluated the positive and negative evidence bearing upon the realizability of our deferred tax assets. Based on the weight of available evidence, both positive and negative, we recorded a valuation allowance of $ 379.7 million and $ 296.0 million as of December 31, 2023 and December 31,... | text | 379.7 | monetaryItemType | text: <entity> 379.7 </entity> <entity type> monetaryItemType </entity type> <context> As required by ASC 740, we have evaluated the positive and negative evidence bearing upon the realizability of our deferred tax assets. Based on the weight of available evidence, both positive and negative, we recorded a valuation al... | us-gaap:DeferredTaxAssetsValuationAllowance |
As required by ASC 740, we have evaluated the positive and negative evidence bearing upon the realizability of our deferred tax assets. Based on the weight of available evidence, both positive and negative, we recorded a valuation allowance of $ 379.7 million and $ 296.0 million as of December 31, 2023 and December 31,... | text | 296.0 | monetaryItemType | text: <entity> 296.0 </entity> <entity type> monetaryItemType </entity type> <context> As required by ASC 740, we have evaluated the positive and negative evidence bearing upon the realizability of our deferred tax assets. Based on the weight of available evidence, both positive and negative, we recorded a valuation al... | us-gaap:DeferredTaxAssetsValuationAllowance |
As required by ASC 740, we have evaluated the positive and negative evidence bearing upon the realizability of our deferred tax assets. Based on the weight of available evidence, both positive and negative, we recorded a valuation allowance of $ 379.7 million and $ 296.0 million as of December 31, 2023 and December 31,... | text | 83.7 | monetaryItemType | text: <entity> 83.7 </entity> <entity type> monetaryItemType </entity type> <context> As required by ASC 740, we have evaluated the positive and negative evidence bearing upon the realizability of our deferred tax assets. Based on the weight of available evidence, both positive and negative, we recorded a valuation all... | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
As required by ASC 740, we have evaluated the positive and negative evidence bearing upon the realizability of our deferred tax assets. Based on the weight of available evidence, both positive and negative, we recorded a valuation allowance of $ 379.7 million and $ 296.0 million as of December 31, 2023 and December 31,... | text | 59.5 | monetaryItemType | text: <entity> 59.5 </entity> <entity type> monetaryItemType </entity type> <context> As required by ASC 740, we have evaluated the positive and negative evidence bearing upon the realizability of our deferred tax assets. Based on the weight of available evidence, both positive and negative, we recorded a valuation all... | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
We will recognize interest and penalties related to uncertain tax positions above the line as an expense to continuing operations. As of December 31, 2023 and 2022, we had no accrued interest or penalties related to uncertain tax positions and no such amounts have been recognized. If all of the Company’s unrecognized t... | text | 28.6 | monetaryItemType | text: <entity> 28.6 </entity> <entity type> monetaryItemType </entity type> <context> We will recognize interest and penalties related to uncertain tax positions above the line as an expense to continuing operations. As of December 31, 2023 and 2022, we had no accrued interest or penalties related to uncertain tax posi... | us-gaap:UnrecognizedTaxBenefits |
Depreciation expense for the years ended December 31, 2023, 2022 and 2021 was $ 6.6 million, $ 8.4 million and $ 8.8 million, respectively. | text | 6.6 | monetaryItemType | text: <entity> 6.6 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2023, 2022 and 2021 was $ 6.6 million, $ 8.4 million and $ 8.8 million, respectively. </context> | us-gaap:Depreciation |
Depreciation expense for the years ended December 31, 2023, 2022 and 2021 was $ 6.6 million, $ 8.4 million and $ 8.8 million, respectively. | text | 8.4 | monetaryItemType | text: <entity> 8.4 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2023, 2022 and 2021 was $ 6.6 million, $ 8.4 million and $ 8.8 million, respectively. </context> | us-gaap:Depreciation |
Depreciation expense for the years ended December 31, 2023, 2022 and 2021 was $ 6.6 million, $ 8.4 million and $ 8.8 million, respectively. | text | 8.8 | monetaryItemType | text: <entity> 8.8 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2023, 2022 and 2021 was $ 6.6 million, $ 8.4 million and $ 8.8 million, respectively. </context> | us-gaap:Depreciation |
On March 25, 2021, we announced that our board of directors authorized a repurchase program, or the Repurchase Program, for the repurchase of up to $ 1.2 billion of our outstanding shares of common stock. On March 31, 2021, in connection with the Repurchase Program, we entered into a definitive share repurchase agreeme... | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> On March 25, 2021, we announced that our board of directors authorized a repurchase program, or the Repurchase Program, for the repurchase of up to $ 1.2 billion of our outstanding shares of common stock. On March 31, 2021, in connecti... | us-gaap:StockRepurchaseProgramAuthorizedAmount1 |
On March 25, 2021, we announced that our board of directors authorized a repurchase program, or the Repurchase Program, for the repurchase of up to $ 1.2 billion of our outstanding shares of common stock. On March 31, 2021, in connection with the Repurchase Program, we entered into a definitive share repurchase agreeme... | text | 7.1 | sharesItemType | text: <entity> 7.1 </entity> <entity type> sharesItemType </entity type> <context> On March 25, 2021, we announced that our board of directors authorized a repurchase program, or the Repurchase Program, for the repurchase of up to $ 1.2 billion of our outstanding shares of common stock. On March 31, 2021, in connection... | us-gaap:TreasuryStockSharesAcquired |
On March 25, 2021, we announced that our board of directors authorized a repurchase program, or the Repurchase Program, for the repurchase of up to $ 1.2 billion of our outstanding shares of common stock. On March 31, 2021, in connection with the Repurchase Program, we entered into a definitive share repurchase agreeme... | text | 344.5 | monetaryItemType | text: <entity> 344.5 </entity> <entity type> monetaryItemType </entity type> <context> On March 25, 2021, we announced that our board of directors authorized a repurchase program, or the Repurchase Program, for the repurchase of up to $ 1.2 billion of our outstanding shares of common stock. On March 31, 2021, in connec... | us-gaap:TreasuryStockValueAcquiredCostMethod |
On March 25, 2021, we announced that our board of directors authorized a repurchase program, or the Repurchase Program, for the repurchase of up to $ 1.2 billion of our outstanding shares of common stock. On March 31, 2021, in connection with the Repurchase Program, we entered into a definitive share repurchase agreeme... | text | 48.38 | perShareItemType | text: <entity> 48.38 </entity> <entity type> perShareItemType </entity type> <context> On March 25, 2021, we announced that our board of directors authorized a repurchase program, or the Repurchase Program, for the repurchase of up to $ 1.2 billion of our outstanding shares of common stock. On March 31, 2021, in connec... | us-gaap:TreasuryStockAcquiredAverageCostPerShare |
Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchased approximately 9.1 million shares of common stock for $ 458.0 million, or $ 50.35 per... | text | 600.0 | monetaryItemType | text: <entity> 600.0 </entity> <entity type> monetaryItemType </entity type> <context> Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchas... | us-gaap:StockRepurchaseProgramAuthorizedAmount1 |
Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchased approximately 9.1 million shares of common stock for $ 458.0 million, or $ 50.35 per... | text | 9.1 | sharesItemType | text: <entity> 9.1 </entity> <entity type> sharesItemType </entity type> <context> Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchased a... | us-gaap:TreasuryStockSharesAcquired |
Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchased approximately 9.1 million shares of common stock for $ 458.0 million, or $ 50.35 per... | text | 458.0 | monetaryItemType | text: <entity> 458.0 </entity> <entity type> monetaryItemType </entity type> <context> Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchas... | us-gaap:TreasuryStockValueAcquiredCostMethod |
Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchased approximately 9.1 million shares of common stock for $ 458.0 million, or $ 50.35 per... | text | 50.35 | perShareItemType | text: <entity> 50.35 </entity> <entity type> perShareItemType </entity type> <context> Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchas... | us-gaap:TreasuryStockAcquiredAverageCostPerShare |
Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchased approximately 9.1 million shares of common stock for $ 458.0 million, or $ 50.35 per... | text | 16.2 | sharesItemType | text: <entity> 16.2 </entity> <entity type> sharesItemType </entity type> <context> Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchased ... | us-gaap:TreasuryStockSharesAcquired |
Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchased approximately 9.1 million shares of common stock for $ 458.0 million, or $ 50.35 per... | text | 802.5 | monetaryItemType | text: <entity> 802.5 </entity> <entity type> monetaryItemType </entity type> <context> Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to which we may repurchase up to $ 600.0 million of shares of our common stock. As of December 31, 2023, we repurchas... | us-gaap:TreasuryStockValueAcquiredCostMethod |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.